Clinical consequences of the polymorphism of azathioprine metabolism.
Thervet
E
E
Service de Néphrologie, Hôpital Saint Louis, Paris, France.
Anglicheau
D
D
Toledano
N
N
Kreis
H
H
Legendre
C
C
Beaune
P
P
D001379:Azathioprine / Q000097:blood* / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000201:enzymology*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008780:Methyltransferases / Q000097:blood* / Q000235:genetics; D011110:Polymorphism, Genetic; D011184:Postoperative Period; D011446:Prospective Studies
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D008780:Methyltransferases; C022745:thiopurine methyltransferase; D001379:Azathioprine